WO2003057671A1 - Compose biaryle et son utilisation - Google Patents
Compose biaryle et son utilisation Download PDFInfo
- Publication number
- WO2003057671A1 WO2003057671A1 PCT/JP2002/013655 JP0213655W WO03057671A1 WO 2003057671 A1 WO2003057671 A1 WO 2003057671A1 JP 0213655 W JP0213655 W JP 0213655W WO 03057671 A1 WO03057671 A1 WO 03057671A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optionally substituted
- hydrocarbon group
- substituted hydrocarbon
- compound
- ring
- Prior art date
Links
- -1 Biaryl compound Chemical class 0.000 title abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 102000004378 Melanocortin Receptors Human genes 0.000 abstract 1
- 108090000950 Melanocortin Receptors Proteins 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02790892A EP1466904A4 (en) | 2001-12-28 | 2002-12-26 | BIARYL CONNECTION AND ITS USE |
US10/499,903 US7507753B2 (en) | 2001-12-28 | 2002-12-26 | Biaryl compound and use thereof |
AU2002367427A AU2002367427A1 (en) | 2001-12-28 | 2002-12-26 | Biaryl compound and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-401303 | 2001-12-28 | ||
JP2001401303 | 2001-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003057671A1 true WO2003057671A1 (fr) | 2003-07-17 |
Family
ID=19189754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/013655 WO2003057671A1 (fr) | 2001-12-28 | 2002-12-26 | Compose biaryle et son utilisation |
Country Status (4)
Country | Link |
---|---|
US (1) | US7507753B2 (ja) |
EP (1) | EP1466904A4 (ja) |
AU (1) | AU2002367427A1 (ja) |
WO (1) | WO2003057671A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1725236A1 (en) * | 2004-03-11 | 2006-11-29 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
US7618987B2 (en) | 2004-07-19 | 2009-11-17 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin 4-receptor agonists |
WO2010056717A1 (en) | 2008-11-17 | 2010-05-20 | Merck Sharp & Dohme Corp. | Substituted bicyclic amines for the treatment of diabetes |
WO2011011508A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
WO2011011506A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
WO2011137024A1 (en) | 2010-04-26 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel spiropiperidine prolylcarboxypeptidase inhibitors |
WO2011143057A1 (en) | 2010-05-11 | 2011-11-17 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
WO2011156246A1 (en) | 2010-06-11 | 2011-12-15 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
US8802679B2 (en) | 2009-09-16 | 2014-08-12 | Astellas Pharma Inc. | Glycine compound |
US9493451B2 (en) | 2011-05-16 | 2016-11-15 | Bionomics Limited | Amine derivatives as potassium channel blockers |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
PT1732933E (pt) * | 2004-03-26 | 2008-10-20 | Lilly Co Eli | Compostos para o tratamento da dislipidémia |
WO2006055553A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2008545008A (ja) * | 2005-06-30 | 2008-12-11 | プロシディオン・リミテッド | Gpcrアゴニスト |
EP1857106A1 (en) * | 2006-05-16 | 2007-11-21 | Edmond Pharma S.R.L. | Combinations of erdosteine and beta-2 agonists for treating COPD |
CA2656620C (en) * | 2006-07-04 | 2018-03-13 | Genmab A/S | Cd20 binding molecules for the treatment of copd |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499415A1 (en) * | 1991-02-11 | 1992-08-19 | Zeneca Limited | Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists |
WO2000074679A1 (en) * | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
WO2001060805A1 (en) * | 2000-02-16 | 2001-08-23 | Smithkline Beecham P.L.C. | Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
WO2002000606A1 (fr) * | 2000-06-28 | 2002-01-03 | Takeda Chemical Industries, Ltd. | Compose biphenyle |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900012875A (ko) | 1989-02-08 | 1990-09-03 | 오스카 아끼히꼬 | 비페닐 유도체, 신경세포 변성수복 또는 보호제 및 여기에 사용되는 폐닐유도체의 제조방법 |
GB9119920D0 (en) | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
CA2200981A1 (en) | 1994-10-04 | 1996-04-11 | Hisashi Takasugi | Urea derivatives and their use as acat-inhibitors |
US6294534B1 (en) | 1998-06-11 | 2001-09-25 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
DE19947457A1 (de) | 1999-10-02 | 2001-04-05 | Aventis Pharma Gmbh | 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
JP2003520850A (ja) | 2000-01-28 | 2003-07-08 | メラキュア セラピューティクス エービー | 新規なメラノコルチン受容体作動薬および拮抗薬 |
GB0002059D0 (en) | 2000-01-28 | 2000-03-22 | Melacure Therapeutics Ab | Novel aromatic amines |
CA2403686C (en) | 2000-03-23 | 2010-01-26 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
WO2001070337A1 (en) | 2000-03-23 | 2001-09-27 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
EP1331010A4 (en) | 2000-08-25 | 2008-08-06 | Takeda Pharmaceutical | PROPHYLACTIC AGENTS AND REMEDIES AGAINST DISEASES OF THE CENTRAL NERVOUS SYSTEM |
JP2004509866A (ja) * | 2000-09-25 | 2004-04-02 | アクテリオン ファマシューティカルズ リミテッド | 置換アミノ−アザ−シクロアルカン |
WO2002026710A1 (fr) * | 2000-09-26 | 2002-04-04 | Tanabe Seiyaku Co., Ltd. | Composes de 5-phenylbenzylamine, procede d'elaboration et intermediaires pour la synthese de ces composes |
JP4820024B2 (ja) | 2001-01-10 | 2011-11-24 | 昭和薬品化工株式会社 | 局所麻酔用組成物 |
US6673829B2 (en) * | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
US6919343B2 (en) * | 2002-02-08 | 2005-07-19 | Merck & Co., Inc. | N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
-
2002
- 2002-12-26 US US10/499,903 patent/US7507753B2/en not_active Expired - Fee Related
- 2002-12-26 AU AU2002367427A patent/AU2002367427A1/en not_active Abandoned
- 2002-12-26 WO PCT/JP2002/013655 patent/WO2003057671A1/ja active Application Filing
- 2002-12-26 EP EP02790892A patent/EP1466904A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499415A1 (en) * | 1991-02-11 | 1992-08-19 | Zeneca Limited | Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists |
WO2000074679A1 (en) * | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
WO2001060805A1 (en) * | 2000-02-16 | 2001-08-23 | Smithkline Beecham P.L.C. | Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
WO2002000606A1 (fr) * | 2000-06-28 | 2002-01-03 | Takeda Chemical Industries, Ltd. | Compose biphenyle |
Non-Patent Citations (1)
Title |
---|
See also references of EP1466904A4 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1725236A4 (en) * | 2004-03-11 | 2009-05-13 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
EP1725236A1 (en) * | 2004-03-11 | 2006-11-29 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
US7618987B2 (en) | 2004-07-19 | 2009-11-17 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin 4-receptor agonists |
WO2010056717A1 (en) | 2008-11-17 | 2010-05-20 | Merck Sharp & Dohme Corp. | Substituted bicyclic amines for the treatment of diabetes |
WO2011011506A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
WO2011011508A1 (en) | 2009-07-23 | 2011-01-27 | Schering Corporation | Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
US8802679B2 (en) | 2009-09-16 | 2014-08-12 | Astellas Pharma Inc. | Glycine compound |
WO2011137024A1 (en) | 2010-04-26 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel spiropiperidine prolylcarboxypeptidase inhibitors |
WO2011143057A1 (en) | 2010-05-11 | 2011-11-17 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
WO2011156246A1 (en) | 2010-06-11 | 2011-12-15 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
US9493451B2 (en) | 2011-05-16 | 2016-11-15 | Bionomics Limited | Amine derivatives as potassium channel blockers |
US9914702B2 (en) | 2011-05-16 | 2018-03-13 | Bionomics Limited | Amine derivatives as potassium channel blockers |
Also Published As
Publication number | Publication date |
---|---|
US20050096359A1 (en) | 2005-05-05 |
US7507753B2 (en) | 2009-03-24 |
AU2002367427A1 (en) | 2003-07-24 |
EP1466904A1 (en) | 2004-10-13 |
EP1466904A4 (en) | 2005-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003057671A1 (fr) | Compose biaryle et son utilisation | |
WO2002062800A1 (fr) | Composé cyclique fondu azoté bicyclique | |
MXPA02012314A (es) | Compuestos de 1,2-dihidropiridina, metodo de fabricacion y utilizacion de los mismos. | |
MXPA03006918A (es) | Compuestos heterociclicos fusionados. | |
EP1527049B8 (en) | Fused heterocyclic compounds as peptidase inhibitors | |
EP1661890A4 (en) | PPAR RECEPTOR ACTIVATION COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUND | |
IL147651A0 (en) | Isoxazoline derivative and herbicide containing the same as the active ingredient | |
EP1288202A4 (en) | N-ACYLTETRAHYDROISOQUINOLINE DERIVATIVES | |
CA2534024A1 (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
TWI265164B (en) | 3-substituted-4-pyrimidone derivatives | |
EP1468990A4 (en) | piperazine derivative | |
WO2005115984A3 (en) | Large conductance calcium-activitated k channel opener | |
ATE175661T1 (de) | Benzamid-derivate als vasopressin-antagonisten | |
CA2128493A1 (en) | Aminobenzoic acid derivatives | |
AU2003207432A1 (en) | Urea linker derivatives for use as ppar modulators | |
AUPP150098A0 (en) | Benzamide derivatives | |
EP1500652A4 (en) | DERIVATIVE AND MEDICINAL PRODUCT OF QUINAZOLINE | |
WO2003004497A1 (fr) | Compose heterocyclique | |
CA2425984A1 (en) | 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their preparation processes and uses | |
WO2003028732A1 (fr) | Antagoniste de recepteur | |
WO1999047132A3 (en) | Heterocyclic compounds, their production and use as tachykinin receptor antagonists | |
WO2004033456A3 (fr) | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique ayant trait au dysfonctionnement des recepteurs nicotiniques | |
HUP0100453A1 (hu) | Eljárás izokarbamidok előállítására | |
EP1666455A4 (en) | CARBOXAMIDE DERIVATIVE OF THE AMIDE TYPE | |
EP1661898A4 (en) | BICYCLIC PIPERAZINE COMPOUND AND USE THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10499903 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002790892 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002790892 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |